Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786721 · ClinicalTrials.gov registry record
Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 9
- Enrollment target
NCT00786721 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 9 participants.
The verdict
NCT00786721 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
There has been increasing support for our hypothesis that mitochondrial dysfunction plays an important role in the etiology of Type 2 Diabetes Mellitus and the overlapping Metabolic Syndrome.
Interventions
- DEVICE Diffuse Optical Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-11 |
| Est. Completion | 2010-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00786721
The ClinicalTrials.gov registry entry for NCT00786721 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.
NCT00786721 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00786721 about?
NCT00786721 is a clinical study titled "Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort". There has been increasing support for our hypothesis that mitochondrial dysfunction plays an important role in the etiology of Type 2 Diabetes Mellitus and the overlapping Metabolic Syndrome.
What is the current status of trial NCT00786721?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2006-11. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00786721?
The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00786721?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.